Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease | Zendy

Eva Lonn | Zendy; Salim Yusuf | Zendy; Malcolm J Arnold | Zendy; Patrick Sheridan | Zendy; Janice Pogue | Zendy; Mary Micks | Zendy; Matthew J McQueen | Zendy; Jeffrey L. Probstfield | Zendy; George Fodor | Zendy; Claes Held | Zendy; Jacques Genest | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

Author(s) -

Eva Lonn,

Salim Yusuf,

Malcolm J Arnold,

Patrick Sheridan,

Janice Pogue,

Mary Micks,

Matthew J McQueen,

Jeffrey L. Probstfield,

George Fodor,

Claes Held,

Jacques Genest

Publication year - 2006

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa060900

Subject(s) - medicine , placebo , relative risk , homocysteine , confidence interval , stroke (engine) , myocardial infarction , liter , vitamin b12 , vascular disease , diabetes mellitus , b vitamins , gastroenterology , surgery , endocrinology , pathology , mechanical engineering , engineering , alternative medicine

In observational studies, lower homocysteine levels are associated with lower rates of coronary heart disease and stroke. Folic acid and vitamins B6 and B12 lower homocysteine levels. We assessed whether supplementation reduced the risk of major cardiovascular events in patients with vascular disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research